Demonstration of novel innate immune cells in psoriasis

Author(s): Mak R, Hundhausen C, Botti E, Laggner U, Grys K, et al.

Abstract

Psoriasis is a common chronic inflammatory skin disorder affecting ~2% of the population worldwide. Both the adaptive and innate immune systems are important in driving the inflammation in genetically susceptible individuals. HLA-Cw6 located within the PSORS1 region on chromosome 6 is the most important psoriasis genetic marker. Correlations of HLA-C expression with different disease incidence and progression are described in the context of HLA-C’s interaction with killer-like immunoglobulin receptors (KIR) expressed on innate immune effector cells; natural killer (NK) and natural killer T (NKT) cells.

Similar Articles

Psoriasis: dysregulation of innate immunity

Author(s): Bos JD, de Rie MA, Teunissen MB, Piskin G

Pathogenesis and therapy of psoriasis

Author(s): Lowes MA, Bowcock AM, Krueger JG

Interleukine-1 and interleukine- 6 in psoriasis

Author(s): Prens EP, Benne K, van DJ, Bakkus M, Brakel K, et al.

The IL-23/ Th 17 Axis in the Immunopathogenesis of Psoriasis

Author(s): Cesare DC, Meglio PD, Nestle FO

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

Author(s): Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, et al.

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Author(s): Chaudhari U, Romano P, Mulcahy L, Dooley L, B aker D, et al.

Histopathologic spectrum of psoriasis

Author(s): Murphy M, Philip K, Grant- Kels JM